85 related articles for article (PubMed ID: 20412195)
1. Combining atomoxetine with carbamazepine or neuroleptics reduces adverse side effects.
Niederhofer H
J Paediatr Child Health; 2010 Jan; 46(1-2):66. PubMed ID: 20412195
[No Abstract] [Full Text] [Related]
2. Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine.
Niederhofer H
Med Hypotheses; 2011 May; 76(5):764-5. PubMed ID: 21397406
[No Abstract] [Full Text] [Related]
3. Acute suicidality after commencing atomoxetine.
Paxton GA; Cranswick NE
J Paediatr Child Health; 2008 Oct; 44(10):596-8. PubMed ID: 19012633
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent Raynaud's phenomenon developing from use of atomoxetine in a girl.
Gökçen C; Kutuk MO; Coşkun Ş
J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):428-30. PubMed ID: 23952193
[No Abstract] [Full Text] [Related]
5. Increased blood pressure and atomoxetine.
Dworkin N
J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):510. PubMed ID: 15908831
[No Abstract] [Full Text] [Related]
6. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
7. Atomoxetine-induced vocal tics in a patient with schizophrenia.
Raveendranathan D; Rao MG; Varambally S; Venkatasubramanian G; Gangadhar BN
J Neuropsychiatry Clin Neurosci; 2012; 24(4):E45-6. PubMed ID: 23224483
[No Abstract] [Full Text] [Related]
8. A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia.
Friedman JI; Carpenter D; Lu J; Fan J; Tang CY; White L; Parrella M; Bowler S; Elbaz Z; Flanagan L; Harvey PD
J Clin Psychopharmacol; 2008 Feb; 28(1):59-63. PubMed ID: 18204342
[TBL] [Abstract][Full Text] [Related]
9. The prevention of relapse in bipolar disorder.
Silverstone T; Romans S
N Z Med J; 1995 Oct; 108(1009):397-8. PubMed ID: 7478331
[No Abstract] [Full Text] [Related]
10. Worsening of bruxism with atomoxetine: a case report.
Mendhekar D; Lohia D
World J Biol Psychiatry; 2009; 10(4 Pt 2):671-2. PubMed ID: 19165653
[TBL] [Abstract][Full Text] [Related]
11. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
12. [Atomoxetine--Strattera. Oral preparation].
Duh PD; Macken E
J Pharm Belg; 2006; 61(4):117-20. PubMed ID: 17263193
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: additional evidence.
Soyka M; Schmidt F; Schmidt P
Pharmacopsychiatry; 2006 Jan; 39(1):30-4. PubMed ID: 16453252
[TBL] [Abstract][Full Text] [Related]
14. Atomoxetine-induced hyponatremia.
Singh T
Aust N Z J Psychiatry; 2007 May; 41(5):458. PubMed ID: 17464740
[No Abstract] [Full Text] [Related]
15. Pharmacological management of a youth with ADHD and a seizure disorder.
Gonzalez-Heydrich J; Weiss M; Connolly M; Wambera K; Jan JE; Plioplys S; Dunn DW; Kratochvil CJ
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1527-32. PubMed ID: 17135999
[No Abstract] [Full Text] [Related]
16. Prolonged penile erections associated with the use of atomoxetine and aripiprazole in an 11-year-old boy.
Goetz M; Surman CB
J Clin Psychopharmacol; 2014 Apr; 34(2):275-6. PubMed ID: 24577257
[No Abstract] [Full Text] [Related]
17. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
18. Atomoxetine treatment of attention-deficit/hyperactivity disorder.
Eiland LS; Guest AL
Ann Pharmacother; 2004 Jan; 38(1):86-90. PubMed ID: 14742801
[TBL] [Abstract][Full Text] [Related]
19. Open-label trial of atomoxetine hydrochloride in adults with ADHD.
Johnson M; Cederlund M; Råstam M; Areskoug B; Gillberg C
J Atten Disord; 2010 Mar; 13(5):539-45. PubMed ID: 19458384
[TBL] [Abstract][Full Text] [Related]
20. Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate.
Prescrire Int; 2010 Feb; 19(105):5-8. PubMed ID: 20455329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
